MR-guided navigation for botulinum toxin injection in the lateral pterygoid muscle. First results in the treatment of temporomandibular joint disorders.

[1]  C. Chen,et al.  Botulinum toxin type A with or without needle electromyographic guidance in patients with cervical dystonia , 2016, SpringerPlus.

[2]  M. Hallett.  Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. , 2015, Toxicon : official journal of the International Society on Toxinology.

[3]  M. Pattussi,et al.  Prevalence of Temporomandibular Disorders in an Adult Brazilian Community Population Using the Research Diagnostic Criteria (Axes I and II) for Temporomandibular Disorders (The Maringá Study). , 2015, The International journal of prosthodontics.

[4]  S. Chuang,et al.  Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. , 2015, International journal of oral and maxillofacial surgery.

[5]  A. Blitzer,et al.  Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection , 2015, Toxins.

[6]  J. Donnellan,et al.  Delayed contrast-enhanced MRI to localize Botox after cystoscopic intravesical injection , 2015, International Urology and Nephrology.

[7]  Antonio Carlos Pires Carvalho,et al.  A Novel Method for Intraoral Access to the Superior Head of the Human Lateral Pterygoid Muscle , 2014, BioMed research international.

[8]  L. Chikhani,et al.  Anatomie descriptive et fonctionnelle de l’articulation temporo-mandibulaire , 2013 .

[9]  Matthew A. Brodsky,et al.  Diffusion of Botulinum Toxins , 2012, Tremor and other hyperkinetic movements.

[10]  E. Ehrmann,et al.  TMD clinical diagnostic classification (Temporo Mandibular Disorders) , 2012 .

[11]  P. Svensson,et al.  Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter study , 2011, PAIN.

[12]  D. Yousem,et al.  CT-Guided Injection of the Anterior and Middle Scalene Muscles: Technique and Complications , 2011, American Journal of Neuroradiology.

[13]  P. Larson,et al.  Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. , 2009, Parkinsonism & related disorders.

[14]  Henry L. Lew,et al.  Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance. , 2009, Archives of physical medicine and rehabilitation.

[15]  Y. Sertdemir,et al.  Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[16]  S. Desmons,et al.  The Lateral Pterygoid Muscle, a Heterogeneous Unit Implicated in Temporomandibular Disorder: A Literature Review , 2007, Cranio : the journal of craniomandibular practice.

[17]  A. Blitzer,et al.  The emerging role of botulinum toxin in the treatment of temporomandibular disorders. , 2007, Oral diseases.

[18]  M. Bakke,et al.  Oromandibular dystonia involving the lateral pterygoid muscles: Four cases with different complexity , 2007, Movement disorders : official journal of the Movement Disorder Society.

[19]  S. Kreiborg,et al.  Treatment of severe temporomandibular joint clicking with botulinum toxin in the lateral pterygoid muscle in two cases of anterior disc displacement. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[20]  M. Guillot,et al.  The anatomical basis for ultrasonography of the lateral pterygoid muscle and the infratemporal fossa , 2005, Surgical and Radiologic Anatomy.

[21]  K. Arndt,et al.  Effect of volume and concentration on the diffusion of botulinum exotoxin A. , 2004, Archives of dermatology.

[22]  O. Doğu,et al.  Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease , 2004, Clinical Neurology and Neurosurgery.

[23]  U. John,et al.  Prevalence of signs and symptoms of temporomandibular disorders in an urban and rural German population: results of a population-based Study of Health in Pomerania. , 2004, Quintessence international.

[24]  P. G. Garcia Ruiz,et al.  Posterior CT guided approach for botulinum toxin injection into spinal psoas , 2003, Journal of Neurology.

[25]  P. Major,et al.  Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain , 2002, Pain.

[26]  H. Shill,et al.  Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia , 2002, Neurology.

[27]  J. V. von Lindern.  Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. , 2001, Acta neurologica Belgica.

[28]  M. Schwartz,et al.  Botulinum toxin: new treatment for temporomandibular disorders. , 2000, The British journal of oral & maxillofacial surgery.

[29]  M. Schwartz,et al.  The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[30]  Z. J. Liu,et al.  Electromyographic examination of jaw muscles in relation to symptoms and occlusion of patients with temporomandibular joint disorders. , 1999, Journal of oral rehabilitation.

[31]  B. Schurch,et al.  Botulinum A toxin as a treatment of detrusor- sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections , 1997, Journal of neurology, neurosurgery, and psychiatry.

[32]  M Lamontagne,et al.  The role of the lateral pterygoid muscles in TMJ disorders during static conditions. , 1997, Cranio : the journal of craniomandibular practice.

[33]  L. Leresche.  Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[34]  I. Sanders,et al.  Quantifying how location and dose of botulinum toxin injections affect muscle paralysis , 1993, Muscle & nerve.

[35]  C. Tanner,et al.  Botulinum toxin injection for spasmodic torticollis , 1992, Neurology.

[36]  C. Chossegros,et al.  Appareil discal de l'articulation temporo-mandibulaire. , 1992 .

[37]  H. Biller,et al.  Quantifying the spread of botulinum toxin through muscle fascia , 1991, The Laryngoscope.

[38]  Davide Cozzolino,et al.  Botulinum a toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread , 1990, Head & neck.

[39]  S. Dworkin,et al.  Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. , 1990, Journal of the American Dental Association.

[40]  L. Dahlström,et al.  Electromyographic studies of craniomandibular disorders: a review of the literature. , 1989, Journal of oral rehabilitation.

[41]  E. N. Gale,et al.  The Effects of Treatment on Masticatory Muscle Activity and Mandibular Posture in Myofascial Pain-dysfunction Patients , 1988, Journal of dental research.

[42]  C H Gibbs,et al.  Superior and inferior bellies of the lateral pterygoid muscle EMG activity at basic jaw positions. , 1983, The Journal of prosthetic dentistry.

[43]  H. Duday,et al.  La place du pterygoidien lateral dans les mouvements de la mandibule , 1982 .